4 unknown, 3 completed, 3 terminated, 2 recruiting. 4 Not applicable, 2 Phase 1, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 1, Enrolling by invitation 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Terminated 2 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Immunosuppressive Agents: new trials by email Literature Review of Immunosuppressive Agents trials Research Report on Immunosuppressive Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure Hydrocortisone Hemisuccinate: 200 mg per day., reduction of the level of immunosuppression - Sepsis and Septic Shock, Acute Respiratory Failure | Phase 4 | Recruiting | University Hospital, Strasbourg, France | 212 | 2026-08-11 | 2026-08-20 |
| Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) Drug-coated balloon, Single antiplatelet therapy (SAPT), Dual antiplatelet therapy (DAPT) - Coronary Disease, Heart Diseases | Not applicable | Recruiting | Fondazione Ricerca e Innovazione Cardiovascolare ETS | 576 | 2026-01-10 | 2026-01-22 |
| Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients SCFA, Placebo - Metabolic Effects, Immunosuppressive Agents | Not applicable | Enrolling by invitation | University Hospital, Martin | 41 | 2025-04-04 | 2025-06-17 |
| Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment venipuncture - Pharmacokinetics, Area Under Curve | Completed | Radboud University Medical Center | 29 | 2024-03-15 | 2025-12-02 | |
| Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients. Short Chain Fatty Acid, Placebo Capsule(s) - Metabolic Effects, Immunosuppressive Agents | Not applicable | Completed | University Hospital, Martin | 41 | 2024-01-15 | 2025-06-12 |
| Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients Kidney Transplantation, Immunosuppressive Agents | Unknown | The Second Affiliated Hospital of Chongqing Medical University | 120 | 2022-07-01 | 2023-09-13 | |
| Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis management of immunosuppressive therapy - Kidney Transplantation, Immunosuppressive Agents | Unknown | Central Hospital, Nancy, France | 430 | 2022-02-01 | 2022-04-05 | |
| Immunosuppressants to Postoperative Infection and Death Immunosuppressive Agents - Organ Transplantation, Immunosuppressive Agents | Unknown | Chung Shan Medical University | 20000 | 2021-12-20 | 2023-11-08 | |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Terminated | Celularity Incorporated | 3 | 2020-10-01 | 2022-08-10 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML CYNK-001 - Leukemia, Leukemia, Myeloid | Phase 1 | Terminated | Celularity Incorporated | 27 | 2020-03-12 | 2024-12-12 |
| Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients Methylprednisolone, Placebo - Pneumocystis, Steroids | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 222 | 2017-02-15 | 2020-10-06 |
| An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens Rapamycin, Everolimus, Prednisone - Comparative Study, Immunosuppressive Agents | Phase 4 | Completed | University Hospital, Basel, Switzerland | 63 | 2008-07-01 | 2010-08-17 |
| MMF and Calcineurin Inhibitor Withdrawal in CAN mycophenolate mofetil (drug) - Immunosuppressive Agents, Kidney Failure, Chronic | Not applicable | Terminated | University Hospital Muenster | 86 | 1999-10-01 | 2005-09-20 |
Hematologic Neoplasms (2) · Neoplasms (2) · Acute Coronary Syndrome (1) · Arterial Occlusive Diseases (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Coronary Stenosis (1) · Glioblastoma (1) · Heart Diseases (1) · Hematologic Diseases (1) · Kidney Failure, Chronic (1) · Leukemia (1) · Leukemia, Myeloid (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hemic and Lymphatic Diseases (2) · Infections (2) · Neoplasms by Site (2) · Arteriosclerosis (1) · Astrocytoma (1) · Bacterial Infections and Mycoses (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glioma (1) · Hematologic Diseases (1) · Inflammation (1)
Everolimus (1) · Fatty Acids, Volatile (1) · Immunosuppressive Agents (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Pharmaceutical Preparations (1) · Phlebotomy (1) · Prednisone (1) · Sirolimus (1) · hydrocortisone hemisuccinate (1)
Celularity Incorporated (2) · University Hospital, Martin (2) · Assistance Publique - Hôpitaux de Paris (1) · Central Hospital, Nancy, France (1) · Chung Shan Medical University (1) · Fondazione Ricerca e Innovazione Cardiovascolare ETS (1) · Radboud University Medical Center (1) · The Second Affiliated Hospital of Chongqing Medical University (1) · University Hospital Muenster (1) · University Hospital, Basel, Switzerland (1) · University Hospital, Strasbourg, France (1)
France (3) · Slovakia (2) · United States (2) · China (1) · Italy (1) · Netherlands (1) · Switzerland (1) · Taiwan (1)
Barbara M Suwelack, PhD (1) · Chien-Ying Lee, PhD (1) · Elie Azoulay, MD PHD (1) · Juerg U Steiger, Professor (1) · Nynke Jager, Dr (1) · Sharmila Koppisetti, M.D (1) · Sharmila Koppisetti, MD (1) · Virginie Lemiale, MD (1)
PMID 15023160, PMID 40652952, PMID 42558999, PMID 42814375
2016 (1)